215 related articles for article (PubMed ID: 25079804)
1. Preclinical Alzheimer's disease therapeutics.
Rafii MS
J Alzheimers Dis; 2014; 42 Suppl 4():S545-9. PubMed ID: 25079804
[TBL] [Abstract][Full Text] [Related]
2. Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications.
Sabbagh JJ; Kinney JW; Cummings JL
Neurobiol Aging; 2013 Jan; 34(1):169-83. PubMed ID: 22464953
[TBL] [Abstract][Full Text] [Related]
3. The evolution of preclinical Alzheimer's disease: implications for prevention trials.
Sperling R; Mormino E; Johnson K
Neuron; 2014 Nov; 84(3):608-22. PubMed ID: 25442939
[TBL] [Abstract][Full Text] [Related]
4. Rethinking the Food and Drug Administration's 2013 guidance on developing drugs for early-stage Alzheimer's disease.
Schneider LS
Alzheimers Dement; 2014 Mar; 10(2):247-50. PubMed ID: 24698029
[TBL] [Abstract][Full Text] [Related]
5. Pro: Are we ready to translate Alzheimer's disease modifying therapies to people with Down syndrome?
Rafii MS
Alzheimers Res Ther; 2014; 6(5-8):60. PubMed ID: 25478025
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease: clinical trials and drug development.
Mangialasche F; Solomon A; Winblad B; Mecocci P; Kivipelto M
Lancet Neurol; 2010 Jul; 9(7):702-16. PubMed ID: 20610346
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials.
Yaffe K; Tocco M; Petersen RC; Sigler C; Burns LC; Cornelius C; Khachaturian AS; Irizarry MC; Carrillo MC
Alzheimers Dement; 2012 May; 8(3):237-42. PubMed ID: 22546356
[TBL] [Abstract][Full Text] [Related]
8. [Toward Preclinical Trials for Alzheimer's Disease].
Miyagawa T; Iwatsubo T
Brain Nerve; 2017 Jul; 69(7):711-722. PubMed ID: 28739984
[TBL] [Abstract][Full Text] [Related]
9. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.
Hampel H; Lista S; Teipel SJ; Garaci F; Nisticò R; Blennow K; Zetterberg H; Bertram L; Duyckaerts C; Bakardjian H; Drzezga A; Colliot O; Epelbaum S; Broich K; Lehéricy S; Brice A; Khachaturian ZS; Aisen PS; Dubois B
Biochem Pharmacol; 2014 Apr; 88(4):426-49. PubMed ID: 24275164
[TBL] [Abstract][Full Text] [Related]
10. Rethinking Alzheimer's disease therapy: are mitochondria the key?
Ankarcrona M; Mangialasche F; Winblad B
J Alzheimers Dis; 2010; 20 Suppl 2():S579-90. PubMed ID: 20463405
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers in Alzheimer's disease drug development.
Cummings JL
Alzheimers Dement; 2011 May; 7(3):e13-44. PubMed ID: 21550318
[TBL] [Abstract][Full Text] [Related]
12. [Molecular pathogenesis and development of disease-modifying drugs for Alzheimer's disease].
Takeda M
Seishin Shinkeigaku Zasshi; 2013; 115(1):32-40. PubMed ID: 23691792
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets.
Prakash A; Kalra J; Mani V; Ramasamy K; Majeed AB
Expert Rev Neurother; 2015 Jan; 15(1):53-71. PubMed ID: 25495260
[TBL] [Abstract][Full Text] [Related]
15. The hunt for drugs to modify Alzheimer's disease.
Butcher J
Lancet Neurol; 2007 Dec; 6(12):1038-9. PubMed ID: 18031701
[No Abstract] [Full Text] [Related]
16. scyllo-Inositol, preclinical, and clinical data for Alzheimer's disease.
Ma K; Thomason LA; McLaurin J
Adv Pharmacol; 2012; 64():177-212. PubMed ID: 22840748
[TBL] [Abstract][Full Text] [Related]
17. The translocator protein as a drug target in Alzheimer's disease.
Chua SW; Kassiou M; Ittner LM
Expert Rev Neurother; 2014 Apr; 14(4):439-48. PubMed ID: 24625007
[TBL] [Abstract][Full Text] [Related]
18. Relevance of the evaluation criteria used in clinical trials for Alzheimer's disease.
Truffinet P; Bordet R; Ménard J
Therapie; 2009; 64(3):139-8. PubMed ID: 19671425
[TBL] [Abstract][Full Text] [Related]
19. Investigational drugs in Alzheimer's disease: current progress.
Berk C; Paul G; Sabbagh M
Expert Opin Investig Drugs; 2014 Jun; 23(6):837-46. PubMed ID: 24702504
[TBL] [Abstract][Full Text] [Related]
20. Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease.
Carrillo MC; Brashear HR; Logovinsky V; Ryan JM; Feldman HH; Siemers ER; Abushakra S; Hartley DM; Petersen RC; Khachaturian AS; Sperling RA
Alzheimers Dement; 2013 Mar; 9(2):123-131.e1. PubMed ID: 23411394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
